Deep dives
With Pebble, our deep-diving penguin. She brings you a pebble of evidence. More from her in the Research hub.
One condition a week, timed to a world health day. Definition to frontier trials, in about ten minutes. For doctors who like their evidence dense and their prose short.
For health professionals New every week. Each covers pathophysiology, epidemiology, preventable factors, current and emerging treatment, prognosis, guidelines and the open questions.
- Deep dive #11 · 17 NovME/CFSPost-exertional malaise, COVID triggers, DecodeME, PACE vs NICE and failed trials.
- Deep dive #10 · 13 NovPelvic congestion syndromeOvarian vein reflux, the bystander debate and what embolisation really shows.
- Deep dive #9 · 10 NovType 2 diabetesOutcome trials, HbA1c pitfalls, remission maths and a crowded incretin pipeline.
- Deep dive #8 · 9 NovADHDAdults in focus: the 5-symptom threshold, effect sizes, 2026 GP prescribing by state, shortages and honest over/under-diagnosis.
- Deep dive #7 · 9 NovAutismAcross the lifespan, adults in focus: 1 in 31, camouflaging, genetics, Wakefield and what supports really do.
- Deep dive #6 · 9 NovMould exposure and healthAsthma, ABPA and hypersensitivity pneumonitis are real; urine mycotoxin tests and CIRS claims, kindly appraised.
- Deep dive #5 · 7 NovPOTSA stand test for Monday, off-label drugs with honest evidence, long COVID and the hEDS–MCAS hype.
- Deep dive #4 · 3 NovProstate cancerPSA maths, overdiagnosis, a new Australian guideline and the Lu-PSMA era.
- Deep dive #3 · 1 NovBehçet's diseaseSilk Road vasculitis: a needle-prick test, deadly aneurysms in young men and the IL-23 vs IL-17 puzzle.
- Deep dive #2 · 31 OctCoeliac diseaseWho to test, no-biopsy rules, gluten thresholds and a drug pipeline graveyard.
- Deep dive #1 · 29 OctStrokeStroke for clinicians: burden, mechanisms, EVT, new trials and evidence gaps.
For health professionals. General education, not a substitute for local protocols or clinical judgement.